undamentalytics Newsletter

Adapthealth Corp. revenue

Adapthealth Corp.'s revenue was $3.24bn in fiscal 2025, down 0.5% on the year before. Since fiscal 2018 ($345m) it has grown at a compound 37.7% a year. Over the last twelve months it was $3.23bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Adapthealth Corp.: revenue history, annual
Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3455301,0562,4552,9713,2003,2613,2453,227
Growth on the year before—+53.4%+99.5%+132.4%+21.0%+7.7%+1.9%−0.5%—
Gross profit5289158446580624681609550
Gross margin15.0%16.8%14.9%18.2%19.5%19.5%20.9%18.8%17.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Sleep Health $1.4B 42.5% ▲ 2.1%
Respiratory Health $691M 21.3% ▲ 6.1%
Diabetes Health $592M 18.3% ▼ 3.6%
Wellness At Home $583M 18.0% ▼ 9.8%

From Adapthealth Corp.'s 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Adapthealth Corp. $3.23bn 4.2% 1.6%
AMN Healthcare Services Inc $3.43bn 24.0% -7.8%
Astrana Health, Inc. $3.84bn 58.9% 43.7%
Chemed Corp $2.66bn 5.2% 6.1%
Aveanna Healthcare Holdings, Inc. $2.60bn 19.5% 12.4%
Hims & Hers Health, Inc. $2.58bn 28.0% 53.7%

Compare with peers

Head to head: AHCO vs AMNAHCO vs ASTHAHCO vs CHE

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Adapthealth Corp.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adapthealth Corp.